In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The closing price of Hims & Hers Health Inc (NYSE: HIMS) was $47.89 for the day, down -4.73% from the previous closing price of $50.27. In other words, the price has decreased by -$4.73 from its previous closing price. On the day, 18.89 million shares were traded. HIMS stock price reached its highest trading level at $50.77 during the session, while it also had its lowest trading level at $47.7603.
Ratios:
Our analysis of HIMS’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 33.22 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 45.56. For the most recent quarter (mrq), Quick Ratio is recorded 1.32 and its Current Ratio is at 1.59. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.11.
On June 04, 2025, Needham reiterated its Buy rating and also lowered its target price recommendation from $61 to $65.
TD Cowen Downgraded its Buy to Hold on April 29, 2025, while the target price for the stock was maintained at $30.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 08 ’25 when Melissa Baird bought 33,333 shares for $48.96 per share.
Okupe Oluyemi sold 11,581 shares of HIMS for $540,498 on Jul 07 ’25. The Chief Financial Officer now owns 58,078 shares after completing the transaction at $46.67 per share. On Jun 30 ’25, another insider, Boughton Soleil, who serves as the Chief Legal Officer of the company, sold 2,572 shares for $50.50 each. As a result, the insider received 129,886 and left with 160,737 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HIMS now has a Market Capitalization of 10719313920 and an Enterprise Value of 10898714624. As of this moment, Hims’s Price-to-Earnings (P/E) ratio for their current fiscal year is 69.71, and their Forward P/E ratio for the next fiscal year is 49.41. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.02. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.01 while its Price-to-Book (P/B) ratio in mrq is 19.49. Its current Enterprise Value per Revenue stands at 6.108 whereas that against EBITDA is 79.161.
Stock Price History:
The Beta on a monthly basis for HIMS is 2.07, which has changed by 1.09676 over the last 52 weeks, in comparison to a change of 0.1116153 over the same period for the S&P500. Over the past 52 weeks, HIMS has reached a high of $72.98, while it has fallen to a 52-week low of $13.47. The 50-Day Moving Average of the stock is -8.92%, while the 200-Day Moving Average is calculated to be 34.68%.
Shares Statistics:
HIMS traded an average of 46.10M shares per day over the past three months and 33502910 shares per day over the past ten days. A total of 215.21M shares are outstanding, with a floating share count of 190.71M. Insiders hold about 14.80% of the company’s shares, while institutions hold 70.41% stake in the company. Shares short for HIMS as of 1749772800 were 61690896 with a Short Ratio of 1.48, compared to 1747267200 on 62338753. Therefore, it implies a Short% of Shares Outstanding of 61690896 and a Short% of Float of 34.23.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
